Results 111 to 120 of about 411,749 (186)

Hypersensitivity Reaction to Insulin Glargine and Insulin Detemir in a Pediatric Patient: A Case Report. [PDF]

J Pediatr Pharmacol Ther, 2016
Badik J, Chen J, Letvak K, So TY.
europepmc   +1 more source

A FAERS database study on visual impairment adverse events associated with three long-acting insulin analogues. [PDF]

Front Endocrinol (Lausanne)
Zhong L, Cao W, Liu X, Wen T, Yan J.
europepmc   +1 more source

Insulin detemir treatment in diabetic cats in a practice setting. [PDF]

J Feline Med Surg, 2015
Hoelmkjaer KM, Spodsberg EM, Bjornvad CR.   +2 more
europepmc   +1 more source

Management of Nocturnal Hypoglycaemia in a Patient with Type 2 Diabetes: The Role of Community Pharmacy. [PDF]

Farm Comunitarios
Nadal Domingo S, Mir Palomo S, Domingo Tortajada D.   +2 more
europepmc   +1 more source

Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia. [PDF]

Clin Case Rep, 2016
Whyte M, Quaglia A, Hopkins D.
europepmc   +1 more source

Central effects of insulin detemir on feeding, body weight, and metabolism in rats.

Am J Physiol Endocrinol Metab, 2017
Vasselli JR, Pi-Sunyer FX, Wall DG, John CS, Chapman CD, Currie PJ.   +5 more
europepmc   +1 more source

Effects of Different Exogenous Insulin Analog Treatments on the Evaluation of Pancreatic Islet Function in Diabetes. [PDF]

J Diabetes Res
Ma YF, Neng QL, Ou Y, Zhou YK.
europepmc   +1 more source

Insulin detemir in pregnancy: a small but significant step forward? [PDF]

Diabetes Care, 2012
McElduff A.
europepmc   +1 more source

Delayed Hypersensitivity Reaction to Insulin: A Case Report. [PDF]

Cureus
Aharmim M, Lakhal M, Reguig N, El Bourkadi JE.   +3 more
europepmc   +1 more source

Undiagnosed type 2 diabetes presenting as diabetic ketoacidosis with hypertriglyceridemia-induced acute pancreatitis. [PDF]

CMAJ
Rathakrishnan SPV, Syed AA, Paisley AN, Kochhar RS.   +3 more
europepmc   +1 more source